TOKYO -- Expectations are rising about the availability of COVID-19 vaccines, as the U.S. announced on Friday it had approved emergency use of one developed by Pfizer and German partner BioNTech.
The U.S. Food and Drug Administration's approval came as the country struggles to curb the highly infectious virus that has now infected more than 15 million people, the most in the world.
.png?width=700&fit=cover&gravity=faces&dpr=2&quality=medium&source=nar-cms&format=auto&height=394)
